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Background: Characterisation of disease associated balanced chromosome rearrangements is a
promising starting point in the search for candidate genes and regulatory elements.
Methods: We have identified and investigated three patients with limb abnormalities and breakpoints
involving chromosome 2q31. Patient 1 with severe brachydactyly and syndactyly, mental retardation,
hypoplasia of the cerebellum, scoliosis, and ectopic anus, carries a balanced t(2;10)(q31.1;q26.3)
translocation. Patient 2, with translocation t(2;10)(q31.1;q23.33), has aplasia of the ulna, shortening of
the radius, finger anomalies, and scoliosis. Patient 3 carries a pericentric inversion of chromosome 2,
inv(2)(p15q31). Her phenotype is characterised by bilateral aplasia of the fibula and the radius, bilateral
hypoplasia of the ulna, unossified carpal bones, and hypoplasia and dislocation of both tibiae.
Results: By fluorescence in situ hybridisation, we have mapped the breakpoints to intervals of
approximately 170 kb or less. None of the three 2q31 breakpoints, which all mapped close to the
HOXD cluster, disrupted any known genes.
Conclusions: Hoxd gene expression in the mouse is regulated by cis-acting DNA elements acting over
distances of several hundred kilobases. Moreover, Hoxd genes play an established role in bone
development. It is therefore very likely that the three rearrangements disturb normal HOXD gene regulation
by position effects.
T
he HOX genes code for a family of highly conserved
transcription factors expressed during embryonic devel-
opment. To date, mutations in four HOX genes, namely
HOXA11, HOXA13, HOXD10, and HOXD13, have been found
and all are associated with limb malformations. In particular,
it has been shown that in two families a single nucleotide
deletion within the second exon of HOXA11, which results in
a frameshift and a premature stop codon, co-segregates with
proximal radial-ulnar synostosis.1 Mutations in HOXA13
cause hand-foot-uterus syndrome, a rare dominantly inher-
ited condition (OMIM 140000),2 and Guttmacher syndrome
(OMIM 176305).3 Recently, a missense mutation in the
HOXD10 gene has been described as the cause of isolated
congenital vertical talus, also known as rocker-bottom feet
(OMIM 192950), and Charcot-Marie-Tooth disease
(OMIM 118220).4 The first human limb malformation shown
to be caused by HOXD13 polyalanine tract expansion
mutations was synpolydactyly (SPD, OMIM 186000).5
Similar pathological polyalanine tract expansions in
HOXD13 have subsequently been reported in other families
with SPD.6–8 Intragenic frameshift deletions in HOXD13,
predicted to result in truncated proteins, and also an acceptor
splice site mutation and a missense mutation in exon 2 of
HOXD13, cause an atypical form of SPD.9–12 Interestingly, a
different missense mutation in the same exon has been
found in a family with a dominantly inherited combination
of brachydactyly and polydactyly.13
Large deletions involving chromosome 2q31.1 have been
associated with minor digital anomalies,14 15 with major limb
defects,15–17 or with a combination of severe limb and genital
abnormalities.18 In contrast, a microdeletion at the 59 end of
the HOXD cluster that removes HOXD9 to HOXD13 and
extends 85 kb upstream of HOXD13 results in an SPD
phenotype.19
Another relevant point to consider is the presence of
regulatory mutations affecting gene expression. Spitz et al
described a balanced t(2;8) translocation that co-segregated
with mesomelic dysplasia and vertebral defects.20 The authors
mapped the chromosome 2 breakpoint approximately 60 kb
downstream from the HOXD cluster. Since no known gene is
disrupted by the rearrangement, the authors speculated that
the translocation affects regulatory sequences of the HOXD
cluster, resulting in misregulation of HOXD gene expression.
In this paper, we report our findings on three unrelated
patients with various skeletal malformations and balanced
rearrangements involving chromosome band 2q31.
METHODS
Subjects
Proband 1 is a 13 year old boy carrying an apparently
balanced chromosome rearrangement t(2;10)(q31.1;q26.3)
(schematically depicted in fig 1A). He is the second child of
healthy unrelated parents, born after a normal pregnancy
and without fetal distress. Clinical examination after birth
revealed severe malformation of the hands and feet as well as
a dysmorphic face. The hands were short and had six fingers,
and absence of the distal phalanges including the nails was
Abbreviations: FISH, fluorescence in situ hybridisation; SPD,
synpolydactyly
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noted. The feet showed complete absence of toes II–V, and a
rudimentary first toe with a missing distal phalanx. x Rays of
the hands showed five short metacarpals and six digits, each
consisting only of a single phalanx. Metacarpal III was
bifurcated at its end, giving rise to two digits. The patient was
not able to fully extend his elbows and knees due to
contractions. Bilateral inguinal hernias were noted and
surgically corrected. x Rays of the thorax showed hypoplasia
of the medial ends of both clavicles. Ultrasound of the skull
revealed hypoplasia of the cerebellum. Further clinical
examinations demonstrated developmental delay, deep set
eyes (left more than right), a progressive scoliosis, narrow
shoulders, ataxia, coxa valga, and short stature (110 cm at
age 6, ,3rd percentile) (fig 2A–D). The hands of the patient
were surgical corrected and the polydactylous digits removed.
The patient has developed well and is currently attending a
special school.
Proband 2 is a 23 year old female carrying a balanced de
novo translocation t(2;10)(q31.1;q23.33) (fig 1B). She is the
first child of healthy parents of Icelandic origin, born at term
after an uncomplicated pregnancy. Except for her extremity
malformation, her motor, mental, and social development
were normal. She has an almost symmetrical limb phenotype
consisting of ulnar aplasia, radial shortening, and absence of
3rd to 5th rays (fig 2E). There is hypoplasia of digits 1 and 2
where one epiphysial disc is shared by the two proximal
phalangeal bones causing articulation between the fingers.
Only one carpal bone is present. Humerus and lower limbs
are normal. A slight dextro-convex scoliosis was found at the
age of 23 (fig 2F). Her mammary glands are normal.
Proband 3 is a newborn girl with a balanced de novo
pericentric inversion inv(2)(p15q31.1). She is the first child
of unrelated parents, a 30 year old mother and a 42 year old
father of German origin. She was born after an uncompli-
cated pregnancy in the 40th week of gestation (birth weight
3700 g, length 49 cm, head circumference 37.5 cm). There
was no history of any medication or illness during pregnancy.
The first radiological examination after birth revealed
bilateral aplasia of the fibula and the radius, bilateral
hypoplasia of the ulna, unossified carpal bones, and
hypoplasia and dislocation of both tibiae.
Breakpoint mapping by fluorescence in situ
hybridisation (FISH)
YAC clones from the regions of interest were used for the
initial mapping of the breakpoints, followed by fine mapping
with smaller clones. FISH was carried out according to
standard procedures. Genomic clones were labelled with
digoxigenin-dUTP or biotin-dUTP and were hybridised to
patient metaphase chromosomes. Signals were detected
either by anti-digoxigenin, FITC, or Cy3 conjugated avidin
and were visualised by fluorescence microscopy with a CCD
camera (Sensys, Photometrics, Tucson, AZ) and an image
analysis program (IPLAB spectrum, Vysis, Downers Grove,
IL). The spotted human chromosome 2-specific cosmid
library (Livermore) was hybridised with a pool of PCR
products selected from the breakpoint region of patient 1.
Positive cosmids were obtained as bacterial stocks from the
Deutsche Ressourcenzentrum fu¨r Genomforschung (RZPD).
DNAs were isolated with the Miniprep Kit (Qiagen, Hilden,
Germany), and their ends were sequenced with T7 and T3
universal primers.
Southern blotting and breakpoint cloning
Genomic DNAs isolated from patient 1 and control cell lines
were digested with BamHI, BglII, HindIII, or PstI restriction
enzymes, separated in 1% agarose gels, transferred onto
nylon membranes (Roth, Karlsruhe, Germany), and hybri-
dised with [a32P]-dCTP labelled PCR products.
Probes for Southern blot hybridisation were amplified
using the following primer sets: 538A12_49750for (59 GCT
TCC CAT TGC AGG TGT AAA 39) and 538A12_49750rev (59
ATT ACT GGT CAT CAA TAT CTA GC 39), 538A12_79400for
(59 AAC TCA ACA TAAACT TTT CCA AAG 39) and
538A12_79400rev (59 GAA TGT AAA ATA TAG ACA TTT
GAC ATT G 39) (positions 104665–105358 and 110085–
110642 of clone RP11-538A12, GenBank accession no.
AC016761).
Breakpoint cloning was performed using adaptor ligated
PCR as described elsewhere.21 EcoRI digested patient DNA
was PCR amplified with a set of nested primers, AP1 (59 GGA
TCC TAA TAC GAC TCA CTA TAG GGC 39) with 84364for (59
CAG ATT GTG ATT AGA TCA GGA G 39) and AP2 (59 TAT
AGG GCT CGA GCG GC 39) with 84715for (59 GAC TTA AAA
TTG CAG CGT GTG TTT C 39) for der(10), and AP1 with
85206rev1 (59 GTG TAT CTA TCT GAG CTC CAT G 39) and
AP2 with 85163rev2 (59 TTC AGC CTT AAG TCA AAA TGT
TGG 39) for der(2). Amplified fragments were isolated from
1% agarose gels, subcloned into pGEM-T Easy vector and
sequenced using M13 universal primers.
Screening for HOXD13 mutation in patient 1
Mutation analysis of the HOXD13 gene in patient 1 included
all coding exons and splice sites. Primers used for PCR
amplifications are available online as supplementary data
available at http://www.jmedgenet.com/supplemental.
Computational analysis of the breakpoint regions
Breakpoint regions were analysed in silico with the NIX
program to identify known or predicted genes and ESTs. All
putative ESTs were screened against entries in GenBank and
TIGR databases.
Patient 1
46,XY,t(2;10)(q31.1;q26.3)
A Patient 2
46,XX,t(2;10)(q31.1;q23.33)
B Patient 3
46,XX,inv(2)(p15q31.1)
2 der(2) der(10) 10 2 der(2) der(10) 10 2 inv(2)
C
Figure 1 Karyotypes of the three patients with apparently balanced chromosome rearrangements and limb malformations included in this study, and
ideograms of the rearranged chromosomes. Arrows point to the breakpoints on der(2), der(10), and inv(2) chromosomes.
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RESULTS
Mapping of the chromosome 2q31 breakpoints by
FISH
FISH performed on patients’ metaphase chromosomes
showed that for patient 1, BAC clone RP11-514D19
(GenBank accession number AC016915), which contains
EVX2 and HOXD8-13, showed signals on chromosome 2 and
on der(10), indicating that the breakpoint lies outside this
region (data not shown). Further hybridisation of a series of
BAC clones selected from the region proximal to EVX2 led to
the identification of the breakpoint-spanning clone RP11-
538A12 (GenBank accession number AC016761) (fig 3A,D).
To map the breakpoint more precisely, PCR products
generated with primers selected from clone RP11-538A12
were used for screening a chromosome 2-specific cosmid
library. Positive clones were hybridised to the patient
chromosomes, and clone LLNLc128F0946 showed a signal
on der(10), whereas clone LLNLc128A0237, with a partially
overlapping sequence, showed a signal on der(2) (fig 3D).
For patient 2, YAC 935E10 (with marker D2S138 and
located at 192 cM) was found to span the 2q31 breakpoint
(data not shown). Thus, the breakpoint of patient 2 was
different from and more distal on chromosome 2q than the
breakpoint of patient 1. This was confirmed by the FISH
results obtained with BAC clone RP11-387A1 (GenBank
accession number AC009336), containing EVX2 and the
complete HOXD cluster, which gave signals on chromosome
2 and on der(2) (data not shown). Hybridisation of BAC
clone RP11-25L17 (GenBank accession number AC096657)
showed split signals on der(2) and der(10), indicating that
this clone spans the breakpoint (fig 3B,D). Furthermore, BAC
clones RP11-1085F24 and RP11-28M17 were also found to be
breakpoint spanning (data not shown). All three breakpoint-
spanning BACs have overlapping sequences, with a common
region of approximately 22 kb. Therefore, it is most likely
that the breakpoint is located within this segment.
For patient 3, YAC clone 888B4 (with markers D2S148 and
D2S2173 and located at 190 cM) was found to span the
chromosome 2q31 breakpoint (fig 3C), indicating that this
breakpoint is different from the two other breakpoints and
lies in the region between the HOXD cluster and the
breakpoint of patient 2. Further FISH studies showed that
BAC clone RP11-724O12 (GenBank accession number
AC079803) spans the breakpoint (data not shown).
In conclusion, FISH mapping revealed that the chromo-
some 2q31 breakpoints investigated in the three patients with
limb malformations lie outside the HOXD cluster: in patient 1
approximately 390 kb centromeric to HOXD13, in patient 2
approximately 1050 kb telomeric to HOXD13, and in patient 3
approximately 590 kb telomeric to HOXD13.
A similar approach was used to map the breakpoints on
chromosome 10. In patient 1, BAC RP11-300B2 (GenBank
accession number AL355531) was breakpoint spanning. In
patient 2, we were able to narrow the region to approximately
28 kb, between the clones RP11-81C11 and RP11-702G14
and clone RP11-348J12 (GenBank accession number
AL358613) (data not shown).
For patient 3, the breakpoint on the short arm of
chromosome 2 was narrowed to a region of approximately
170 kb between clones RP11-351H12 (GenBank accession
numbers AQ529149 and AQ529148) and RP11-355A23
(GenBank accession number AC009490) (data not shown).
Cloning of the breakpoints of patient 1
In order to localise precisely the chromosome 2 breakpoint of
patient 1, we performed Southern blot hybridisation of
patient and control DNAs digested with appropriate restric-
tion enzymes. Since there is an approximately 4.5 kb long
LINE repeat in the region of interest, we were very restricted
with respect to designing probes. The two probes designed
from sequences close to the repeat were most informative.
Hybridisation of the more telomeric probe (538A12_49750)
allowed observation of aberrant restriction fragments in
patient DNA digested with BamHI, whereas the more
Figure 2 (A,B) Pictures of patient 1 at the age of 10. (C) Photo of the
right hand of patient 1. (D) x Ray of the right hand of patient 1. Note the
shortened metacarpals, webbing, duplications, and shortening of digits;
(E) x Ray of the left arm of patient 2 at the age of 10 demonstrating ulnar
aplasia, shortened radius, and absent 3rd to 5th rays. Furthermore,
there is hypoplasia of digits 1 and 2. (F) x Ray of the spine of patient 2 at
the age of 23 revealing a slight dextro-convex scoliosis. (G) Babygram
of proband 3. Note severe defects in distal limbs.
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centromeric probe (538A12_79400) showed aberrant restric-
tion fragments in patient DNA cut with BglII (fig 4A,B).
Mapping of the breakpoint on chromosome 10 gave us
additional information about restriction sites on der(2) and
der(10) chromosomes, and we found that EcoRI should be
useful for our further analyses. In order to clone the
breakpoint of chromosome 2, we ligated adaptors to EcoRI
digested patient DNA. Subsequent PCR reactions gave rise to
two products, approximately 500 bp long for der(10) and
approximately 1.1 kb long for der(2), which were subcloned
and sequenced. The breakpoint on chromosome 2 is located
between positions 107 910 bp and 107 912 bp of clone RP11-
538A12. The nucleotide G at position 107 911 bp is deleted;
moreover, on der(2), a 9 bp insertion is present between
original chromosome 2 and chromosome 10 sequences
(fig 4C).
HOXD13 is not mutated in patient 1
The limb malformations of patient 1 resemble those present
in patients with SPD and a mutation in HOXD13. Our
mutation analysis of HOXD13 showed normal results. Hence,
the phenotype is most likely caused by the translocation.
Computational analysis of the breakpoint regions
In silico analysis showed that there is no known gene on the
chromosome 2q31 breakpoint-spanning BAC (RP11-538A12)
in patient 1. For patient 2, we identified no known gene in
the 22 kb long breakpoint interval; the closest gene
(hnRNPA3) is located approximately 45 kb telomeric to the
breakpoint region. For patient 3, sequence analysis of the
breakpoint-spanning BAC (RP11-724O12) revealed the
presence of three short unspliced ESTs, all derived from
either cancer cells or stomach tissues, but none of these ESTs
belongs to any known gene.
Our analysis of the chromosome 10 breakpoint region of
patient 1 revealed that this breakpoint disrupts the MGMT
gene, which encodes methylguanine-DNA methyltransferase,
an enzyme involved in DNA repair processes. MGMT is
expressed from the intact chromosome 10 in the patient cell
line (data not shown); thus, the breakpoint on chromosome
10 may play no role in the phenotype.
The breakpoint on chromosome 10 in patient 2 was
mapped within a 28 kb region of the breakpoint-spanning
BAC clone RP11-348J12. This region contains three genes:
SEC15L1 and two cytochrome P450 genes, CYP26A1 and
CYP26C1. The product of the human SEC15L1 gene is highly
similar to the yeast protein SEC15, which is one of the
components of a multiprotein complex required for exocy-
tosis. To date, there is no indication that SEC15L1 plays a role
in limb development. CYP26 family members of the
cytochrome P450 catabolise and contribute to the control of
retinoic acid, an important regulator of gene expression
during embryonic development.22 23 The Cyp26a12/2 knock-
out mice show caudal truncation, vertebrae transformation,
and hindbrain mispatterning. Moreover, in these mice the
hindlimbs are fused, whereas no abnormalities of the upper
limb structures are visible.24 The absence of lower limb
malformations in patient 2 suggests that CYP26A1 is not
involved in the observed upper limb malformations.
The breakpoint region on the short arm of chromosome 2
in patient 3 has been mapped to an interval of approximately
170 kb. This region contains no known gene.
Figure 3 FISH mapping of the 2q31 breakpoints in the patients. (A) Hybridisation of the breakpoint spanning clone RP11-538A12 to patient 1
chromosomes; arrows indicate signals on chromosome 2, der(2), and der(10). (B) FISH results for patient 2 with RP11-25L17, the breakpoint spanning
BAC; arrows indicate signals on the normal and the derivative chromosomes. (C) Metaphase showing the breakpoint spanning YAC 888B4 in patient 3
with signals on the normal chromosome 2 and split signals on the inverted chromosome 2. (D) Schematic map of the 2q31.1 band showing the location
of the three breakpoints in the vicinity of the HOXD complex together with breakpoint-spanning BAC and cosmid clones; known genes from this region
are depicted schematically. Approximate distances from the breakpoints to the HOXD13 gene are indicated by double headed arrows (not drawn to
scale).
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DISCUSSION
In the present study we have investigated three unrelated
patients with severe limb malformations and apparently
balanced chromosome rearrangements involving chromo-
some 2q31 and located close to the HOXD complex. It is
noteworthy that computational analysis of each breakpoint
region in 2q31 provided no indication that any known genes
are directly truncated by the breakpoints. However, the
patients show phenotypes characteristic for HOXD mutations
which strongly suggests that the limb abnormalities are the
result of disturbed HOXD expression through the chromoso-
mal breakpoints rather than a coincidence of affected limb
development by other mechanisms.
In patient 1, the phenotype resembles that of patients with
SPD. The most common mutation causing SPD is an
expansion of the imperfect trinucleotide repeat coding for
alanine in the HOXD13 gene. Sequence analysis of the
HOXD13 genes in patient 1 showed a normal result, which
suggests that the phenotype is instead caused by effects of
the translocation. It has been proposed that SPD is not only
caused by a loss of function of the HOXD13 gene but also by a
combined loss of function of several HOXD genes. This
conclusion has been drawn from experiments done in the
mouse. Hoxd13 homozygous knock-out mice show a fairly
mild phenotype25 26 which resembles neither that of patients
with SPD nor that of spdh mice.27 Interestingly, mice with a
deletion encompassing Hoxd11, Hoxd12, and Hoxd13 show a
much more severe limb phenotype, comparable to that of the
homozygous spdh mouse.28 Results obtained by several groups
indicate that the posterior genes, Hoxa13, Hoxd11, Hoxd12, and
Hoxd13, contribute significantly to digit development, and
that these genes control this process in a dose-dependent
manner, whereas Hoxa11 and Evx2, the latter located at the
centromeric end of the Hoxd complex, showed only a minor
contribution to digit morphogenesis.29 We propose, therefore,
that in patient 1 the translocation has an impact on the
regulation of HOXD expression, which results in the HOXD
loss of function phenotype. Aberrant gene expression caused
by a change of the gene’s chromosomal environment,
referred to as a position effect, can be the result of various
mechanisms, one of which is the separation of regulatory
elements from their respective transcription unit, leading to
misexpression (reviewed by Kleinjan and van
Heyningen30 31). Intensive studies in the mouse led to the
hypothesis that Hoxd10, Hoxd11, Hoxd12, and Hoxd13 genes,
which show very similar expression domains in presumptive
digits,32 are under the control of the same digit enhancer that
controls their spatial and temporal expression in developing
limbs. Furthermore, it has been suggested that this digit
enhancer is located centromeric to the Hoxd complex.33 Many
attempts have been made to find this enhancer sequence,34 35
but its precise location remains unknown. Introduction of a
human PAC clone covering almost the entire HOXD cluster
and extending approximately 40 kb centromeric to HOXD13
could not rescue the phenotype in mice which were triple
mutants for Hoxd11/Hoxd12/Hoxd13, suggesting that the
enhancer is located even further away from the cluster.36
More recently, a fragment of human DNA from the region
more centromeric to the HOXD cluster has been shown to
contain transcriptional enhancer activity similar to that
controlling both Hoxd and Evx2 genes.37 This DNA segment
is part of human BAC clone RP11-504O20 (GenBank
accession number AC016751), which partially overlaps with
BAC 538A12, the clone spanning the breakpoint in patient 1.
Spitz et al37 have also analysed BAC 538A12 but could not
show any enhancer activity specific for posterior HOXD genes.
It is thus very likely that the presumed digit enhancer lies
close to the breakpoint in patient 1; however, it seems to be
neither disrupted nor separated from the HOXD cluster by the
breakpoint.
In patients 2 and 3, the 2q31 breakpoints are located on the
telomeric side of the HOXD cluster, and both patients show
malformations of more proximal parts of the limbs. In patient
2, the ulnae and the posterior digits in the hands are absent
while the radii are hypoplastic. Patient 3 has no radii, ulnae,
or fibulae, and shows hypoplastic tibiae. Improper develop-
ment of the lower arm and lower legs has been described in
mice lacking either Hoxd11 or Hoxa11 genes, as well as in the
double mutants.38–42 Additionally, in Hoxd11 knock-out mice,
metacarpals, phalanges, and wrist bones are affected.39 40
Compound mutants for Hoxa10 and Hoxd11, as well as
Hoxa10 and Hoxd10 double knock outs, showed more severe
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Figure 4 (A) Schematic representation of the breakpoint region on BAC
RP11-538A12 and the localisation of probes 538A12_ 79400 and
538A12_ 49750 (shown as grey boxes) used for Southern blot
hybridisation. The positions and sizes of normal restriction fragments are
indicated and enzymes are marked as follows: B, BglII; BH, BamHI; H,
HindIII; P, PstI; the striped box between the two probes indicates the LINE
repeat. (B) Southern blot analysis with probe 538A12_ 49750; DNA
from patient 1 (P) and a control (C) were digested with HindIII or BamHI
restriction enzymes; the presence of additional bands in the patient
compared to the control (arrows) indicates that the breakpoint is located
within the HindIII and BamHI restriction fragments. (C) Chromosome 2,
10, der(2), and der(10) sequences in patient 1. Chromosome 2-derived
sequences are shown in bold; the underlined guanine residue from
chromosome 2 is missing in both derivative chromosomes. The 9 bp
insertion of unknown origin within der(2) (shaded box) separates
chromosome 2- and chromosome 10-derived sequences.
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phenotypes, suggesting that, as for digit formation, zeugopod
development is dependent on the correct expression of
several posterior Hoxd genes.43 44 In addition to the knock-
out mice, a regulatory mutation in the mouse has been
described. Ulnaless is a semidominant x ray induced muta-
tion, which changes the level of posterior Hoxd expression in
limb buds.33 45 The phenotype is very severe, with affected
zeugopods and almost complete absence of ulnae, which
resembles the phenotypes of patients 2 and 3. It has recently
been shown that an inversion occurred on chromosome 2 in
the ulnaless mouse, near the Hoxd cluster. The size of the
inversion is approximately 770 kb, with one breakpoint
centromeric to the Hoxd cluster disrupting the Lnp gene,
and the other breakpoint, which probably does not truncate
any gene, telomeric to the Hoxd cluster.37 Although the
authors highlighted the relevance of the centromeric break-
point for the ulnaless phenotype, our results for patients 2 and
3, together with a recent hypothesis about the early limb
control region present on the telomeric site of the Hoxd
cluster in mouse,46 suggest that the ulnaless breakpoint
telomeric to Hoxd may also play a role in the observed
zeugopod malformations. In line with this is the transloca-
tion t(2;8) described by Spitz et al,20 which is also associated
with abnormal zeugopod development. In this translocation,
the chromosome 2 breakpoint is located closer to the HOXD
cluster than the breakpoint in patient 3 described in the
present study. Similarly to the patients described in this
study, however, no obvious gene was disrupted by the
rearrangement. These findings indicate that sequences
telomeric to the HOXD genes also play an important role in
the regulation of the entire cluster. In light of this, it is likely
that the limb phenotypes in patients 2 and 3 are the result of
aberrant HOXD expression through the breakpoints telomeric
to the HOXD cluster.
Other position effect mechanisms can also lead to gene
silencing, either by insertion of a gene into a heterochromatic
region or by removal of a long range insulator, which
normally allows spreading of heterochromatin over long
distances. However, it is rather unlikely that one of these
mechanisms has caused misregulation of HOXD genes in
patient 1, since the whole HOXD cluster and all currently
known regulatory elements have been translocated into a
transcriptionally active region at 10q26 containing the MGMT
gene. Similarly, in patient 2, the breakpoint at 10q23.33 lies
within a region containing several genes. Therefore, the
phenotypes of these patients are more likely caused by
translocation mediated disturbances in other mechanisms;
for instance, the rearrangements might have brought the
HOXD cluster into the vicinity of regulatory elements present
near the second breakpoint. Alternatively, another transcrip-
tion unit from the non-HOXD breakpoint regions could
compete with the HOXD genes for the digit enhancer or for
the early limb control region, resulting in misregulation of
the HOXD genes. Both hypotheses are interesting, however
given the present state of knowledge, they are only
speculative. At the moment, nothing is known about
regulatory elements of MGMT or other genes in the vicinity
of the breakpoint at 10q26 (EBF3 and TXNL2 are located
approximately 330 kb and 630 kb telomeric to the chromo-
some 10 breakpoint in patient 1, and MKI67 is located
approximately 1.4 Mb centromeric to this breakpoint), which
could theoretically influence expression of the translocated
HOXD cluster. Moreover, nothing is currently known about
the presence of putative cis-acting regulators in the break-
point regions at 10q23 and 2p15 in patients 2 and 3.
Expression of posterior HOXD genes in limb buds is most
likely regulated by the interplay between cis-acting elements
and trans-acting factors. To date, two groups of genes, namely
Polycomb (PcG) and trithorax (trxG) have been implicated in
maintenance of the active or silent state of Hox genes in
Drosophila (for review see Simon47) and mammals (reviewed
in Schumacher and Magnuson48). Results from the last few
years suggest that PcG genes may also play a role in controlling
expression of posterior Hoxd genes in mouse limb buds by
integrating both local and global regulatory mechanisms.49 50
However, it has been shown that binding of different trans-
acting regulators to DNA might be dependent on intact
chromatin architecture.51 52 Since it has been proposed that
the chromatin structure of any locus is determined by the
combination of cis-acting elements and the wider chromosomal
and nuclear environment,31 it is plausible that chromosome
rearrangements could influence chromatin architecture and
thereby result in misregulation of genes. In fact, changes in
chromatin structure have been proposed following insertion of
some transgenes,53 or in the case of small deletions.54
Interestingly, changes in the global chromatin structure
might also influence expression of other genes near the
breakpoints at 2q31. The closest gene, located only 220 kb
telomeric to the breakpoint in patient 1, is KIAA1715. This
gene is transcribed from the strand opposite that of the HOXD
cluster. Its mouse homologue, Lnp, shows the same expres-
sion pattern in limb buds and external genitalia as Hoxd13
and Evx2, which suggests that all three genes are under the
control of the same regulatory sequences. In addition, Lnp is
also expressed in the developing central nervous system in a
highly similar pattern to that of Evx2, and it has a specific
expression domain in the eyes, the heart, and the forebrain.37
The neural enhancer that may activate KIAA1715 is located in
part within the same 40 kb region as the digit enhancer
mentioned earlier; therefore, it is possible that both the limb
and the neuronal expression domains of KIAA1715 have been
affected by the translocation via a position effect. Since
patient 1 has cognitive deficits in addition to limb abnorm-
alities, it is tempting to link the central nervous system
phenotype with disturbed expression of the KIAA1715 gene.
Although theoretically possible, it seems rather unlikely
that the breakpoints on chromosome 10 and on the short arm
of chromosome 2 cause the phenotypes of the patients
reported here. The breakpoint at 10q26 in patient 1 disrupts
the MGMT gene encoding the DNA-repair enzyme methyl-
guanine-DNA methyltransferase; however, we observed
expression of this gene from the intact chromosome 10 in
patient lymphoblastoid cell lines. Moreover, MGMT2/2
knock-out mice are essentially normal,55 apart from being
somewhat smaller than controls.56 For patient 2, three genes,
SEC15L1, CYP26A1, and CYP26C1, reside on the chromosome
10-derived breakpoint-spanning clone RP11-348J12; how-
ever, misexpression of none of these genes could explain her
phenotype. In patient 3, the breakpoint in the short arm of
chromosome 2 was mapped to an interval of approximately
170 kb. This interval and also its flanking DNA stretches,
including 600 kb of 39 sequence and 500 kb of 59 sequence,
harbour no known genes.
In summary, the data presented in this paper are plausible
examples of regulatory mutations underlying severe devel-
opmental defects. They illustrate the complexity of HOXD
cluster regulation and highlight the importance of the precise
regulation of these genes for proper limb development.
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